Logo - Reynolds, 150th Anniversary

Archives: News

BAT Group subsidiary Reynolds American Inc. scores 100% in Human Rights Campaign Foundation’s 2021 Corporate Equality Index

By

For the second consecutive year, the BAT Group subsidiary earns top marks on the Human Rights Campaign’s annual assessment of LGBTQ workplace equality WINSTON-SALEM, N.C. – Jan. 28, 2021 – For the second consecutive year, the BAT Group’s U.S. subsidiary Reynolds American Inc. and its operating companies (Reynolds), scored 100% on the Human Rights Campaign Foundation’s 2021 Corporate Equality Index (CEI), the nation’s … Continued

News Brief: BAT progresses COVID-19 candidate vaccine into Phase I human clinical trials

By

BAT’s US Bio-tech arm, Kentucky BioProcessing (KBP) today announced plans to commence a Phase I first-time-in-human study of its COVID-19 vaccine candidate following approval of its Investigational New Drug application by the U.S. Food and Drug Administration (FDA). Enrollment for the study is expected to begin shortly. Full press release, intended for use by the media only, available … Continued

Reynolds receives Great Place to Work®, Best Workplace designations

By

More than 85% of employees call Reynolds a Great Place to Work WINSTON-SALEM, N.C., Sept. 10, 2020– For the fourth consecutive year, Reynolds American Inc. (Reynolds) has been certified as a Great Place to Work® and has again been named by FORTUNE Magazine as one of its 2020 Best Workplaces. With more than 85% of employees stating that the … Continued

VELO Pouch Premarket Tobacco Applications Submitted to FDA for Review by Reynolds

By

VELO pouch is second group of PMTAs for VELO products, and completes current VELO brand PMTA submissions  WINSTON-SALEM, NC. September 1, 2020 – Reynolds American Inc. (“Reynolds”) announces today the submission of a group of Premarket Tobacco Product Applications (“PMTAs”) to the U.S. Food and Drug Administration (“FDA”) seeking orders authorizing the marketing of VELO pouches. … Continued

Reynolds Submits First VELO Dissolvable Nicotine Lozenge Premarket Tobacco Product Applications

By

FDA applications are a first for VELO’s dissolvable nicotine lozenges WINSTON-SALEM, N.C. – August 24, 2020 – Reynolds American Inc. (“Reynolds”) announces today the submission of a group of Premarket Tobacco Product Applications (“PMTAs”) to the U.S. Food and Drug Administration (“FDA”) seeking orders authorizing the marketing of VELO dissolvable nicotine lozenges. A grant of these … Continued

Statement from Reynolds American

By

Reynolds stands against racism and discrimination in all forms, and we condemn all acts of hate against African Americans and other groups. Our recruitment of a diverse workforce in order to create a culture of inclusion where employees are treated equally will continue to be one of our top priorities. We have a long way … Continued

Reynolds Submits Second and Third Complete Premarket Tobacco Product Applications

By

Vuse Vibe and Vuse Ciro join Reynolds’ Prior Vuse Solo Submission to FDA WINSTON-SALEM, N.C. – April 15, 2020 – Reynolds American (“Reynolds”) announced today that it has submitted two new Premarket Tobacco Product Applications (“PMTAs”) to the U.S. Food and Drug Administration (“FDA”). Reynolds is seeking marketing orders for their Vuse Vibe and Vuse Ciro … Continued

BAT Working on Potential COVID-19 Vaccine Through US Bio-tech Subsidiary

By

Potential vaccine in development for COVID-19 using new, fast-growing tobacco plant technology – pre-clinical testing under way Tobacco plants offer the potential for faster and safer vaccine development compared to conventional methods Potential to manufacture 1-3 million doses of vaccine per week April 1, 2020: BAT’s US bio-tech subsidiary, Kentucky BioProcessing (KBP), is developing a potential vaccine for … Continued